TipRanks on MSN15d
FDA approves Johnson & Johnson’s TREMFYA in Crohn’s diseaseJohnson & Johnson announced that the FDA has approved TREMFYA, or guselkumab, the first and only IL-23 inhibitor offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback